This topic contains a solution. Click here to go to the answer

Author Question: A high-mass star dies more violently than a low-mass star because A) it must always end up as a ... (Read 82 times)

DyllonKazuo

  • Hero Member
  • *****
  • Posts: 565
A high-mass star dies more violently than a low-mass star because
 
  A) it must always end up as a black hole.
  B) it generates more heat and its core eventually collapses very suddenly.
  C) it cannot fuse elements heavier than carbon.
  D) gravity is weakened by its high luminosity.
  E) it is most often found as part of a binary system.

Question 2

A loop of gas following the magnetic field lines between sunspots' poles is:
 
  A) a flare.
  B) a ray.
  C) a coronal hole.
  D) a prominence.
  E) a coronal mass ejection.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

princessflame2016

  • Sr. Member
  • ****
  • Posts: 298
Answer to Question 1

B

Answer to Question 2

D





 

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

A good example of polar molecules can be understood when trying to make a cake. If water and oil are required, they will not mix together. If you put them into a measuring cup, the oil will rise to the top while the water remains on the bottom.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library